Ushbu ishga iqtibos qilgan ishlar

15 ta ish

Ish: Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

1. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study

   Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov +14

   MaqolaTuberculosis Research and EpidemiologyPLoS ONE20154 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000023

2. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Jane Greig +5

   MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 iqtibos

   ABIABI:AkademIndex/openalex/2016.article.000054

3. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   MaqolaTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.195695

4. Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan

   Stefan Köhler, Damin Asadov, Andreas Bründer +4

   MaqolaTuberculosis Research and EpidemiologyHealth Economics Review20162 iqtibos

   ABIABI:AkademIndex/openalex/2016.article.000128

5. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

   Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

   MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.000207

6. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

   Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

   MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.262609

7. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms

   Stefan Köhler, Damin Asadov, Andreas Bründer +4

   MaqolaHIV/AIDS Impact and ResponsesThe International Journal of Tuberculosis and Lung Disease20142 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.364601

8. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

   MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 iqtibos

   ABIABI:AkademIndex/openalex/2018.article.000181

9. Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

   A. Engström, Uladzimir Antonenka, Abdylat Kadyrov +10

   MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20191 iqtibos

   ABIABI:AkademIndex/openalex/2019.article.000129

10. Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +11

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos

    ABIABI:AkademIndex/openalex/2021.article.000489

11. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

    Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.262608

12. Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +9

    MaqolaTuberculosis Research and EpidemiologyPLoS ONE20170 iqtibos

    ABIABI:AkademIndex/openalex/2017.article.000063

13. Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018

    Zayniddin Sayfutdinov, Ajay Kumar, Dilyara Nabirova +5

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 iqtibos

    ABIABI:AkademIndex/openalex/2021.article.000692

14. Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?

    Laziz Turaev, Ajay Kumar, Dilyara Nabirova +3

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 iqtibos

    ABIABI:AkademIndex/openalex/2021.article.001408

15. Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan

    Jamshid Gadoev, Anthony Harries, Oleksandr Korotych +7

    Tahririyat maqolasiDiverse Scientific Research StudiesInternational Journal of Environmental Research and Public Health20210 iqtibos

    ABIABI:AkademIndex/openalex/2021.editorial.000002